Photodynamic therapy for Taiwanese patients with pathologic myopia: A 2-year follow-up

Retina

Volumn 27, Issue 7, 2007, Pages 839-845

  Chen, Ying Shan ^a,c   Lin, Jack Yu Shih ^b   Tseng, Shih Yu ^a   Yow, Shew Gin ^a   Hsu, Wen Jin ^a   Tsai, Show Chuan ^a  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NONE   (Taiwan)

Author keywords

Pathologic myopia; Photodynamic therapy; Subfoveal choroidal neovascularization; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MYOPIA; PHOTODYNAMIC THERAPY; PROGNOSIS; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STUDENT T TEST; SUBRETINAL NEOVASCULARIZATION; TAIWAN; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; FOVEA CENTRALIS; HUMANS; MALE; MIDDLE AGED; MYOPIA, DEGENERATIVE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; PROSPECTIVE STUDIES; TAIWAN; VISUAL ACUITY;

EID: 34748824982     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31804b1e6f     Document Type: Article

References (16)

1. Montero JA, Ruiz-Moreno JM. Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularization. Br J Ophthalmol 2003;87:173-176.
2. Wong TY, Foster PJ, Hee J, et al. Prevalence and risk factors for refractive errors in adult Chinese in Singapore. Invest Ophthalmol Vis Sci 2000;41:2486-2494.
3. Yoshida T, Ohno-Matsui K, Yasuzumi K, et al. Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 2003;110:1297-1305.
4. Blinder KJ, Blumenkranz MS, Bressler NM, et al. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial - VIP report no. 3. Ophthalmology 2003;110:667-673.
5. Keam SJ, Scott LJ, Curran MI. Verteporfin: a review of its use in the management of subfoveal choroidal neovascularisation. Drugs 203;63:2521-2554.
6. Lam DS, Chan WM, Liu DT, et al. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospect series of 1 to 2 year follow up. Br J Ophthalmol 2005;88:1315-1319.
7. Avila MP, Weiter JJ, Jalkh AE, et al. Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 1984;91:1573-1581.
8. Vrouenraets MB, Visser GWM, Snow GB, van Dongen GAMS. Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Research 2003;23:505-522.
9. Holladay JT. Proper method for calculating average visual acuity. J Refract Surg 1997;13:388-391.
10. Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. One-year results of a randomized clinical trial - VIP report no. 1. Ophthalmology 2001;108:841-852.
11. Yoshida T, Ohno-Matsui K, Ohtake Y, et al. Long-term visual prognosis of choroidal neovascularization in high myopia: a comparison between age groups. Ophthalmology 2002;109:712-719.
12. Schimidt-Erfurth U, Schlotzer-Schrehard U, Cursiefen C, et al. Influence of photodynamic therapy on expression of vascular endothelial growth factor (VEGF), VEGF receptor 3, and pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2003;44:4473-4480.
13. Schmidt-Erfurth U, Michels S, Barbazetto I, Laqua H. Photodynamic effects on choroidal neovascularization and physiological choroid. Invest Ophthalmol Vis Sci 2002;43:830-841.
14. Wang YS, Friedrichs U, Eichler W, et al. Inhibitory effects of triamcinolone acetonide on bFGF-induced migration and tube formation in choroidal microvascular endothelial cells. Graefes Arch Clin Exp Ophthalmol 2002;240:42-48.
15. Eyetech Study Group. Anti-vascular endothelial growth factor therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration: phase II study results. Ophthalmology 2003;110:979-986.
16. Spaide RF, Sorenson J, Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2005;112:301-304.